June 26th 2024
Adrienne G. Waks, MD, discusses efforts to address unmet needs in HER2-positive breast cancer.
July 28th 2023
Adrienne G. Waks, MD, discusses treatment alternatives in the third line and beyond for patients with metastatic HER2-positive breast cancer.
June 9th 2023
Adrienne G. Waks, MD, discusses breast cancer survival in patients with small node-negative HER2-positive breast cancer according to the treatment modality received.
July 14th 2022
Adrienne G. Waks, MD, discusses the continued evaluation of immunotherapy in HER2-positive breast cancer.